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Obstructive sleep apnoea (OSA) is independently associated with various
cardiovascular diseases, including myocardial infarction and stroke. OSA may
promote atherosclerosis risk factors such as hypertension, diabetes and
dyslipidaemia, and may have direct proatherogenic effects on the vascular wall. A
growing number of studies have recently focused on the role of microparticles (MPs)
in the atherogenic process. MPs are small plasma membrane vesicles that can be
released by a variety of vascular or blood cells, and contain both membrane and
cytosolic elements. Case–control studies have shown that platelet-, endothelium- and
leukocyte-derived MP levels are increased in OSA. Experimental evidence has
demonstrated that MPs from OSA patients induce endothelial dysfunction,
inflammation and vascular hyperreactivity when injected into mice. In this review, we
provide an overview of the main characteristics of MPs, their expression in OSA and
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